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ABSTRACT
Purpose: The aim of this study was to describe differences in long-term outcomes for patients discharged
to inpatient rehabilitation facilities (IRFs) following stroke compared to patients discharged directly home
or to residential aged care facilities (RACFs).
Materials and methods: Cohort study. Data from the Australian Stroke Clinical Registry were linked to
hospital admissions records and the national death index. Main outcomes: death and hospital readmis-
sions up to 12months post-admission, Health-related Quality of Life (HRQoL) 90-180days post-admission.
Results: Of 8,555 included patients (median age 75, 55% male, 83% ischemic stroke), 4,405 (51.5%) were
discharged home, 3,442 (40.2%) to IRFs, and 708 (8.3%) to RACFs.
Results: No between-group differences were observed in hazard of death between patients discharged to
IRFs versus home. Fewer patients discharged to IRFs were readmitted to hospital within 90, 180 or 365-
days compared to patients discharged home (adjusted subhazard ratio [aSHR]:90-days 0.54, 95%CI 0.49,
0.61; aSHR:180-days 0.74, 95%CI 0.67, 0.82; aSHR:365-days 0.85, 95%CI 0.78, 0.93). Fewer patients dis-
charged to IRFs reported problems with mobility compared to those discharged home (adjusted OR 0.54,
95%CI 0.47, 0.63), or to RACFs (aOR 0.35, 95%CI 0.25, 0.48). Overall HRQoL between 90-180days was worse
for people discharged to IRFs versus those discharged home and better than those discharged to RACFs.
Conclusions: Several long-term outcomes differed significantly for patients discharged to different set-
tings after stroke. Patients discharged to IRFs reported some better outcomes than people discharge dir-
ectly home despite having markers of more severe stroke.
 IMPLICATIONS FOR REHABILITATION
 People with mild strokes are usually discharged directly home, people with moderate severity strokes
to inpatient rehabilitation, and people with very severe strokes are usually discharged to residential
aged care facilities.
 People discharged to inpatient rehabilitation reported fewer problems with mobility and had a
reduced risk of hospital readmission in the first year post-stroke compared to people discharged dir-
ectly home after stroke.
 The median self-reported health-related quality of life for people discharged to residential aged care
equated to ‘worst health state imaginable’.
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Introduction
Stroke is a leading cause of death and disability globally, and it is
estimated that one in five Australians will have a stroke within their
lifetime [1]. Strong evidence exists to support immediate medical
attention and access to stroke unit (SU) care for all people with
stroke [2]. Following admission to the SU, recommendations regard-
ing care become more divergent, being dependent on clinical fac-
tors, health system resources and patient preferences.
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There are no clear recommendations regarding when and
where to discharge patients from the acute hospital, but patterns
regarding discharge from Australian SUs have been observed [3].
Lengths of stay have been steadily decreasing (from median
7 days in 2010 [4] to 4 days in 2017 [5]). Stroke survivors with mild
or no apparent signs of stroke tend to be discharged directly
home; survivors who are alert with obvious sensorimotor or lan-
guage impairment tend to be discharged to inpatient rehabilita-
tion facilities (IRFs); and survivors with severe symptoms like
dense hemiplegia, dysphagia and reduced alertness tend to be
discharged directly to residential aged care facilities (RACFs, some-
times referred to as nursing homes) [3] which provide long-term
care for people who can no longer live at home.
Little is known about differences in long-term outcomes of
patients discharged to different settings after stroke. By compar-
ing the patterns within the cohorts of patients discharged to dif-
ferent settings using data from our national stroke registry, we
may be able to identify opportunities to improve long-term out-
comes for all patients with stroke.
The objective of this multicentre, prospective, observational
study was to describe long-term outcomes (mortality, hospital
readmissions, and quality of life) for patients following acute
stroke either discharged to home, IRFs or to RACFs.
Given the observed patterns of different patient cohorts being
discharged to different destinations, we hypothesized that
patients discharged to IRFs would i) have worse long-term out-
comes than patients discharged directly home, and ii) better
long-term outcomes than patients discharged directly to RACFs.
Methods
Datasets
This study originates from the Stroke123 project whereby patient-
level data from the Australian Stroke Clinical Registry (AuSCR)
were linked and merged with routinely collected administrative
data from five jurisdictions, previously described [6,7]. Data from
patients admitted to 39 acute hospitals with stroke or transient
ischaemic attack (TIA) who were registered in the AuSCR between
2009 and 2013 were linked to the National Death Index, as well
as hospital emergency department and admissions records from
four Australian states (Victoria, New South Wales, Queensland,
Western Australia) using patient identifiers with 98% matching. All
hospitals contributing data to the AuSCR were included. Hospital
administrative data included a 5-year look-back period (including
the index event) to maximize information on comorbidities.
AuSCR includes information from all patients with stroke and
TIA admitted to participating hospitals who do not opt out of the
registry. Data are collected during the hospital admission based
on a nationally endorsed minimum dataset including demo-
graphic and clinical information, quality of care indicators and dis-
charge outcomes including discharge destination [8]. Follow-up
data [health-related quality of life (HRQoL)] were collected once
per patient via questionnaires posted to eligible patients 90-
180 days after their stroke, with telephone follow-up if question-
naires were not returned. Surveys could be completed by patients
or their caregivers. Eligibility for participation in the follow-up sur-
vey included having a first-recorded stroke, having data registered
in AuSCR within 180 days of stroke and being alive at 90 days
post-stroke.
Data from 2010 to 2103 were used for the current study.
Additional exclusion criteria were: admission for TIA (by definition,
there is no permanent neurological damage, so any requirement
for rehabilitation or long term care would be related to factors
other than the TIA); discharge to settings other than home/private
residence, IRF or RACF; missing discharge destination; age
under 18 years.
Hospital admissions data contain morbidity data
(International Classification of Diseases, 10th revision, Australian
modification [ICD-10-AM] diagnosis codes), and administrative
data on all admitted patient episodes to public or private hospi-
tals. Data from emergency department presentations were not
used in this study.
The National Death Index provides information on date and
primary and secondary ICD-10-AM coded cause of death. These
data are linked with AuSCR annually to update mortality
information.
Outcomes and definitions
The outcomes were all-cause death and all-cause hospital read-
missions during the first 12-months following discharge from the
acute hospital for the index stroke event, and self-reported
HRQoL at 90-180 days post-stroke. Acute hospital readmissions
were obtained from the linked hospital administrative records. All
cases where patients were admitted and separated on the same
date (related to rehabilitation, chemotherapy, radiotherapy, dialy-
sis and palliative care) were excluded. HRQoL was assessed using
the generic EuroQoL 5-dimensional questionnaire (EQ-5D) [9] with
three levels of responses for each domain. The EQ-5D has been
shown to be valid and responsive for stroke [10], and displays
acceptable accuracy when filled out by a proxy [11]. Answers
were dichotomized as ‘no problems’ or ‘any problems’ for each
domain, and a visual analog scale (VAS) for overall HRQoL, rang-
ing from 0 (worst health state imaginable) to 100 (best health
state imaginable). For the 478 patients who died within 180-days,
the VAS was coded as ‘zero’ to address survivor bias.
Patient demographic data, clinical characteristics, quality of
care indicators, discharge destination and HRQoL were obtained
from the AuSCR. Information on comorbidities was obtained from
the hospital admissions data, allowing Charlson Comorbidity
Index (CCI) scores [12] to be calculated using a validated algo-
rithm for ICD-10-AM codes [13]. The CCI has consistently been
shown to be a valid and reliable prognostic indicator [14], includ-
ing for patients with stroke [15]. Patients were assigned to cate-
gories defined by the CCI score 0 (none), 1 (moderate), 2 (severe),
and 3 or more (very severe) [15].
Information about the acute hospitals (e.g., location, bed num-
bers and teaching status) was provided by the hospitals to the
AuSCR Office. Patients’ socioeconomic positions were determined
using the postcode-based Index of Relative Socioeconomic
Advantage/Disadvantage using information provided by the
Australian Bureau of Statistics [16].
Statistical methods
Patient and hospital-related factors of patients discharged to the
three different discharge destinations were tallied (Table 1).
Differences in mortality between groups (IRF versus home, IRF
versus RACF) at 90, 180 and 365 days following the index stroke
admission date were assessed using Cox proportional hazards
regression analysis. Differences in hospital readmissions were eval-
uated using competing risks multiple regression models, with
death as a competing risk, giving adjusted subhazard ratios
(aSHR). Sensitivity analyses were conducted to account for the
time spent in IRFs not captured in our data (median length of
stay [LOS] in IRFs was 26 days in 2012 [17]). This was done by
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comparing death and readmissions at 90, 180 and 365 days for
patients discharged home and to RACF to these outcomes at 120,
210 and 395days for patients discharged to IRFs (i.e., timepoint þ
30 days), excluding deaths or readmissions within the first 30 days
for this group. Differences between groups in HRQoL VAS scores
were assessed using quantile regression analyses. Between-group
differences for each of the five dichotomized dimensions of the
EQ-5D were assessed using logistic regression.
All multivariable models were adjusted for the same pre-speci-
fied patient, clinical and hospital characteristics [age, sex, birth-
place, socioeconomic advantage, CCI, dementia, previous stroke,
stroke type, ability to walk unaided on admission (global measure
of disability that can reliably predict survival and independence at
time of hospital discharge [18,19]), in-hospital stroke (a stroke that
occurs when a person has been admitted to hospital for a differ-
ent condition), SU care, hospital location, size and teaching sta-
tus]. Multi-level models were used with level defined as patient
and hospital to adjust for patient clustering within hospitals. Data
were analyzed using StataIC 14.0.
Ethical considerations
The Stroke123 data linkage project was approved by Monash
University (CF13/1303-2013000641), in addition to site-specific
approvals. Additional ethics approvals were obtained from the
Australian Institute for Health and Welfare (EO2013/2/16) for link-
age of the AuSCR registrants’ data to National Death Index data,
and from the state health departments in New South Wales
(HREC/14/CIPHS/66), Queensland (HREC/13/QPAH/31), Victoria
(HREC/14/CIPHS/66) and Western Australia (#2015/33).
Results
Data were available for 14,744 patients registered in AuSCR with
stroke or TIA from 2010-2013. Data from 8,555 patients with
stroke were included following exclusion of patients diagnosed
with TIA (n¼ 2,684, 18.2%); discharged to settings other than
home/private residence, IRF or RACF (n¼ 1,748, 11.9%), e.g., acute
hospital transfer; died in hospital (n¼ 1,364, 9.3%); missing dis-
charge destination (n¼ 380, 2.6%) and aged under 18 years
(n¼ 13, 0.1%) (Figure 1). The median age of included patients was
75 years, 54.9% were male and 82.6% experienced ischaemic
strokes (Table 1).
Mortality
Overall, 961 (11%) of included patients died within 12months
of stroke.
After adjusting for baseline factors, there were no between-
group differences in hazard of death for patients discharged to
IRFs compared to those discharged directly home. Patients dis-
charged to IRFs had a reduced hazard for death compared to
patients discharged to RACFs; adjusted Hazard Ratio 0.27 (95%CI
0.19, 0.38) at 90 days (Table 2). This observation persisted up to
12-months post-stroke, and remained when sensitivity analysis
accounted for the extra time the IRF cohort spent in the hospital
system (Supplemental Table I).
Readmissions
More than half the sample (n¼ 4555, 53.2%) were readmitted to
hospital in the 12months following discharge. Circulatory system
diseases (ICD-10 codes I00-I99) were the most common primary
diagnosis of first readmissions, being responsible for 973 (21.4%)
first readmissions. After adjusting for baseline factors, patients dis-
charged to IRFs were less likely than patients discharged directly
home to be readmitted within days 90, 180 and 365 following dis-
charge from the acute hospital (aSHR:90-days 0.54, 95%CI 0.49,
0.61; aSHR:180-days 0.74, 95%CI 0.67, 0.82; aSHR:365-days 0.85,
95%CI 0.78, 0.93), Table 3. These differences remained when
Table 1. Description of sample.
Patients discharged to Inpatient rehabilitation (N¼ 3442) Home (N¼ 4405) Residential care (N¼ 708) All patients (N¼ 8555)
Age
under 65 years 703 (20.4) 1522 (34.6) 19 (2.7) 2244 (26.3)
65–74 773 (22.5) 1189 (27.0) 75 (10.6) 2037 (23.8)
75–84 1198 (34.8) 1171 (26.6) 238 (33.7) 2607 (30.5)
85þ 766 (22.3) 518 (11.8) 375 (53.0) 1659 (19.4)
Male 1829 (53.2) 2621 (59.6) 241 (34.1) 4691 (54.9)
Born in Australia 2233 (64.9) 2825 (64.1) 452 (63.8) 5510 (64.4)
Relative socioeconomic advantage:
Quintile 1 537 (15.6) 761 (17.3) 91 (12.9) 1389 (16.2)
Quintile 2 719 (20.9) 682 (15.5) 90 (12.7) 1491 (17.4)
Quintile 3 566 (16.4) 727 (16.5) 111 (15.7) 1404 (16.4)
Quintile 4 592 (17.2) 905 (20.5) 125 (17.7) 1622 (19.0)
Quintile 5 1028 (30.0) 1330 (30.2) 291 (41.1) 2649 (1.0)
Charlson comorbidity index, median (Q1, Q3) 3 (3, 5) 3 (1, 4) 4 (3, 6)
History of dementia 222 (6.5) 130 (3.0) 204 (28.8) 556 (6.5)
Documented previous stroke 657 (19.8) 753 (18.2) 197 (29.3) 1607 (19.8)
Stroke type:
Intracerebral hemorrhage 513 (14.9) 405 (9.2) 121 (17.1) 1039 (12.2)
Ischaemic 2831 (82.3) 3674 (83.7) 551 (77.8) 7056 (82.6)
Undetermined 97 (2.8) 311 (7.1) 36 (5.1) 444 (5.2)
Able to walk independently on admission 778 (24.1) 2432 (61.4) 75 (11.2) 3285 (41.8)
In-hospital stroke 222 (6.5) 121 (2.8) 44 (6.2) 387 (4.6)
Received stroke unit care 3023 (87.8) 3629 (82.4) 507 (71.6) 7159 (83.7)
Major city 2856 (83.0) 3607 (81.9) 615 (86.9) 7078 (82.7)
Hospital> 300 beds 2778 (80.7) 3552 (80.6) 616 (87.0) 6946 (81.2)
Teaching hospital 1772 (51.5) 1929 (43.8) 348 (49.2) 4049 (47.3)
Length of stay, median (Q1, Q3) 8 (5, 13) 4 (2, 7) 13.5 (5, 28) 6 (3, 11)
Values presented as n (%) unless otherwise stated.
Q1: 25th percentile; Q3: 75th percentile. Higher quintiles indicate greater socioeconomic advantage.
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sensitivity analysis accounted for the extra time the IRF cohort
spent in the hospital system (Supplemental Table II).
Patients discharged to IRFs were more likely than patients dis-
charged to RACF to be readmitted within 365 days (aSHR:365 days
1.34, 95%CI 1.16, 1.55). Results comparing readmissions between
the IRF and RACF group for 90 and 180 days were less clear, with
inconsistencies between the main and sensitivity analyses
(Supplemental Table II).
Health-related quality of life at 90–180 days
Follow-up survey data were available for 4818 patients (73% of
those eligible to participate, Supplemental Table III), with
responses for 1001 (20.8%) participants completed by someone
other than the person with stroke. Percentages of survey respond-
ents who had been discharged to home, IRF and RACF were simi-
lar to the overall sample (Supplemental Table IV). Eligible patients
who completed follow-up were older, with shorter LOS, less often
identified as being Aboriginal and/or Torres Strait Islander, more
often received SU care and experienced an ischaemic stroke than
eligible patients who did a complete follow-up.
The median HRQoL VAS score reported by respondents was 70
(Q1 40, Q3 80), see Figure 2. More than half of the sample
reported problems with usual activities (59.9%) and mobility
(55.3%). Problems with pain/discomfort (49.5%) and anxiety/
depression (47.4%) were also commonly reported. After adjusting
for baseline factors, patients discharged to IRFs reported lower
Figure 1. Flow diagram of patients included in the analysis.
Figure 2. Data from visual analog scale: health-related quality of life (EQ5-D).
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HRQoL than patients discharged directly home (coefficient 6.50,
95%CI 8.34, 4.66) and higher HRQoL than patients discharged
to RACFs (coefficient 43.42, 95%CI 39.60, 47.24). Patients dis-
charged to IRFs were less likely to report problems with mobility
compared to those discharged directly home or to RACFs (Table
4). However, these people were more likely to report problems
with self-care, usual activities, pain/discomfort, and anxiety/
depression than people discharged directly home.
Discussion
This research provides new knowledge about the associations
between discharge destination and mortality, hospital readmis-
sions, and HRQoL in large numbers of people in the first year
after stroke. The three patient groups compared in our analysis
are likely to represent different bands of stroke severity, given the
differing proportions of patients who could walk independently
on admission to hospital, which has been shown to be a reliable
proxy for stroke severity in large datasets [19]. In the group dis-
charged directly home, the majority (61.4%) could walk independ-
ently on admission, likely comprising patients with mild stroke. In
contrast, only 24.1% of patients discharged to IRFs could walk
independently on admission, likely representing those with mod-
erate and severe stroke. In the group discharged to RACFs, only
11.5% of patients could walk independently on admission. We are
unable to report how many of these patients lived in RACFs prior
to their stroke.
Our data highlight unexpected advantages for patients dis-
charged to IRFs over patients discharged directly home. We
hypothesized that patients who were discharged to IRFs would
have worse long-term outcomes than patients discharged directly
home. However, despite the cohort who were discharged to IRFs
being older and having indicators of more severe stroke, they had
similar mortality (after adjusting for comorbidities), were less likely
to be readmitted to hospital and reported fewer problems with
mobility than patients discharged directly home. As anticipated,
overall HRQoL was worse for these patients. It may be that the
longer LOS for patients discharged to IRFs (8 days in hospital, plus
approximately 3-4weeks in IRF vs 4 days for patients discharged
home) allows for comprehensive discharge planning which tends
to occur suboptimally in Australia; in previous work, only 52% of
patients who were discharged directly home after stroke received
discharge care plans [20], and only 18% received all aspects of
discharge care planning [21]. The extra time spent in inpatient
settings by patients admitted to IRFs may assist in preparing
patients and their families for living with the long-term effects of
stroke, inclusive of ongoing rehabilitation and secondary stroke
prevention. For those discharged directly home, we cannot report
the proportion who received rehabilitation at home or in a com-
munity setting, but nationally only 4% of patients with stroke
access home rehabilitation [22]. Patients with mild physical
impairments following stroke who do not receive rehabilitation
can experience ongoing difficulties with community mobility [23],
which may account for the higher prevalence of self-reported
mobility problems in the group discharged directly home. Given
the unanticipated comparatively poor outcomes for patients dis-
charged directly home, it would appear that supports such as
information provision, discharge planning and rehabilitation rou-
tinely offered in IRFs should be considered for people discharged
directly home through the use of services such as early supported
Table 2. Cumulative survival up to 90, 180 and 365 days among patients accessing inpatient rehabilitation versus discharge to home or residential care.
Time point (days)











Within 90 156 (4.5) 100 (2.3) 198 (28.0) 1.10 (0.81, 1.49) 0.27 (0.19, 0.38)
180 265 (7.7) 170 (3.9) 263 (37.2) 1.12 (0.91, 1.39) 0.26 (0.20, 0.35)
365 395 (11.5) 251 (5.7) 315 (44.5) 1.18 (0.99, 1.41) 0.31 (0.25, 0.39)
Random effects multi-level, Cox proportional hazards regression adjusted for baseline differences; significant associations (p<0.05) are shown in bold.
Table 3. Cumulative readmissions within 90, 180 and 365 days among patients accessing inpatient rehabilitation versus discharge to home or residential care.
Time point (days)











Within90 594 (17.3) 1142 (25.9) 157 (22.2) 0.55 (0.49, 0.61) 0.77 (0.65, 0.92)
180 1175 (34.1) 1655 (37.6) 221 (31.2) 0.74 (0.67, 0.82) 1.13 (0.97, 1.33)
365 1788 (52.0) 2293 (52.1) 290 (41.0) 0.85 (0.78, 0.93) 1.34 (1.16, 1.55)
Random effects multi-level, multivariable competing risks regression, with death as a competing risk, adjusted for baseline differences; significant associations
(p<0.05) are shown in bold.
Table 4. Health-related quality of life between 90 and 180 days among patients accessing inpatient rehabilitation versus discharge to home or residential care.
EQ-5D Domain (respondents for domain)
Number reporting any problems (%) Adjusted odds ratioa (95% CI)
Rehabilitation Home Residential care Rehabilitation vs home Rehabilitation vs residential care
Mobility (n¼ 4800) 837 (42.0) 1683 (65.3) 131 (57.0) 0.54 (0.47, 0.63) 0.35 (0.25, 0.48)
Self-care (n¼ 4804) 975 (49.0) 416 (16.1) 212 (91.8) 3.03 (2.59, 3.56) 0.14 (0.08, 0.24)
Usual activities (n¼ 4796) 1525 (76.6) 1128 (43.8) 220 (95.7) 2.83 (2.44, 3.28) 0.26 (0.13, 0.50)
Pain or discomfort (n¼ 4763) 1148 (58.2) 1062 (41.3) 148 (67.0) 1.47 (1.28, 1.69) 0.83 (0.59, 1.16)
Anxiety or depression (n¼ 4758) 1098 (55.8) 1011 (39.4) 146 (66.1) 1.50 (1.31, 1.73) 0.75 (0.53, 1.05)
Visual analogue scale (n¼ 5252) 60 (39, 79)b 75 (60, 90)b 0 (0, 45)b –6.50 (–8.34, 4.66)c 43.42 (39.60, 47.24)c
aRandom effects multi-level, logistic regression adjusted for baseline differences; significant associations (p<0.05) are shown in bold.
bReported as median (Quartiles 1 and 3).
cRandom effects multi-level, quantile regression analysis adjusted for baseline differences. Reported as coefficient (95% CI).
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discharge which have proven effectiveness in reducing disability
and hospital LOS for people with mild to moderate disability fol-
lowing stroke [24].
As anticipated, mortality and HRQoL outcomes for patients dis-
charged directly to RACFs were worse than those of patients dis-
charged to IRFs. The proportion of patients discharged directly to
RACFs was relatively small (8.3% of sample). These patients were
more likely to be aged over 85 years, have dementia and were
less likely to receive SU care than patients discharged to IRFs. The
current analysis cannot determine causality, so it is unclear
whether the patients discharged to RACFs were less likely to sur-
vive so were managed palliatively in the acute hospital and fol-
lowing discharge. Another possibility is that the greater mortality
rates may be associated with a nihilistic approach to service provi-
sion for this group, with less access to SU care and IRFs, despite
evidence that patients with severe stroke and cognitive impair-
ment benefit from inpatient rehabilitation [25,26]. Outcomes for
these patients were extremely poor with median HRQoL VAS
score of 0 equating to ‘worst health state imaginable’. The median
LOS for this group was 13.5 days, therefore it would be logical to
trial reorganization of the hospital system and provide rehabilita-
tion during this inpatient stay for patients who are anticipated to
survive their stroke with a view to improving outcomes, includ-
ing HRQoL.
Study limitations
Strengths of this study include the large nationally representative
cohort of patients with confirmed stroke diagnoses, and the use
of linked data which has allowed increased information on comor-
bidities and examination of long-term mortality and readmissions
for the first time in the Australian context. Limitations of this
work are the lack of detailed information about stroke severity
(the National Institutes of Health Stroke Scale has only recently
been introduced as part of routine collection in AuSCR), impair-
ments at time of discharge, pre-stroke place of residence and the
infrastructure and activity of stroke rehabilitation services. Further,
it is plausible that a person’s HRQoL may be affected by their
post-discharge place of residence which we did not account for.
There may also be other sources of bias or confounding. Not all
eligible participants returned the follow-up questionnaire and
there were some differences in patient profiles for those who did
or did not respond which may have over or underestimated the
estimates of HRQoL, including the fact that some responses were
filled out by a proxy rather than the patient themselves.
Conclusions
Our findings suggest that patients discharged to IRFs after stroke
experience disproportionately fewer hospital readmissions and
problems with mobility than patients discharged directly home,
despite having markers of more severe stroke. Rehabilitation pro-
vided to people in settings other than IRFs (i.e., provided to
patients who are discharged directly home or to RACFs after
stroke) may need to be improved to adequately address these
patients’ ongoing needs.
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